Adial Pharmaceuticals
ADIL
$1.44
Share price
-3.67%
Change (1 day)
381.67%
Change (1 year)
Categories
Adial Pharmaceuticals (ADIL) - P/B ratio
P/B ratio as of May 2024 : 2.60
According to Adial Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 2.60.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Adial Pharmaceuticals - P/B ratio (from 2018 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.9684 | -45.04% |
| 2022-12-31 | 1.76 | -89.07% |
| 2021-12-31 | 16.1 | 162.65% |
| 2020-12-31 | 6.14 | 76.26% |
| 2019-12-31 | 3.48 | -55.82% |
| 2018-12-31 | 7.88 | |
| 2017-12-31 | N/A | |
| 2016-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -6.34 | -344.01% | Bahamas |
 NRC Health
NRC | 15.1 | 482.64% | 🇺🇸 USA |